Cargando…

Real-World COVID-19 Vaccine Protection Rates against Infection in the Delta and Omicron Eras

The real-world vaccine protection rates (VPRs) against the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection are critical in formulating future vaccination strategies against the virus. Based on a varying coefficient stochastic epidemic model, we obtain 7 countries’ real-world V...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yuru, Gu, Jia, Qiu, Yumou, Chen, Song Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AAAS 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202182/ https://www.ncbi.nlm.nih.gov/pubmed/37223465 http://dx.doi.org/10.34133/research.0099

Ejemplares similares

Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants
por: Jia, Liqiu, et al.
Publicado: (2022)

Estimation of Real-World Vaccination Effectiveness of mRNA COVID-19 Vaccines against Delta and Omicron Variants in Japan
por: Kodera, Sachiko, et al.
Publicado: (2022)

Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)
por: Barbui, Tiziano, et al.
Publicado: (2022)

Real world effectiveness of tixagevimab/cilgavimab (Evusheld) in the Omicron era
por: Chen, Benjamin, et al.
Publicado: (2023)

COVID-19 Vaccines against Omicron Variant: Real-World Data on Effectiveness
por: Kherabi, Yousra, et al.
Publicado: (2022)

Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model
por: Yadav, Pragya D., et al.
Publicado: (2022)

Real-world effectiveness of mRNA COVID-19 vaccines in the elderly during the Delta and Omicron variants: Systematic review
por: Palalay, Harvey, et al.
Publicado: (2023)

Chimeric mRNA-based COVID-19 vaccine induces protective immunity against Omicron and Delta variants
por: Hu, Qidong, et al.
Publicado: (2022)

Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine
por: Li, Wanting, et al.
Publicado: (2023)

Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
por: Xu, Kun, et al.
Publicado: (2022)

Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant
por: Khan, Khadija, et al.
Publicado: (2022)

Better strategies for containing COVID-19 pandemic: a study of 25 countries via a vSIADR model
por: Yan, Han, et al.
Publicado: (2021)

Comparing containment measures among nations by epidemiological effects of COVID-19
por: Gu, Jia, et al.
Publicado: (2020)

291. Retrospective Study on Bacteremia in COVID-19 Patients in the Delta and Omicron Era
por: Park, Sunghee, et al.
Publicado: (2022)

Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection
por: Suah, Jing Lian, et al.
Publicado: (2022)

Resurgence of Influenza Circulation in the Russian Federation during the Delta and Omicron COVID-19 Era
por: Sominina, Anna, et al.
Publicado: (2022)

Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
por: Norddahl, Gudmundur L., et al.
Publicado: (2022)

Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes
por: Buchan, Sarah A., et al.
Publicado: (2022)

Omicron infection enhances Delta antibody immunity in vaccinated persons
por: Khan, Khadija, et al.
Publicado: (2022)

Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine
por: Lu, Changrui, et al.
Publicado: (2023)

A booster with SARS-CoV-2 vaccines: protection against Omicron infection
por: Hu, Yuehong, et al.
Publicado: (2022)

Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history
por: Lavezzo, Enrico, et al.
Publicado: (2022)

Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients
por: Zhang, Lei, et al.
Publicado: (2023)

Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
por: Andeweg, Stijn P., et al.
Publicado: (2022)

Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
por: Hajnik, Renee L., et al.
Publicado: (2022)

Protective Effect of Inactivated COVID-19 Vaccines against Omicron BA.2 Infection in Guangzhou: A Test-Negative Case-Control Real-World Study
por: Zhang, Dingmei, et al.
Publicado: (2023)

Protective Effect of Inactivated COVID-19 Vaccines against Progression of SARS-CoV-2 Omicron and Delta Variant Infections to Pneumonia in Beijing, China, in 2022
por: Li, Juan, et al.
Publicado: (2022)

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

Will New Variants Emerge after Delta and Omicron?
por: Yang, Zhen, et al.
Publicado: (2022)

Modeling the Impact of Vaccination on COVID-19 and Its Delta and Omicron Variants
por: Wang, Jianbo, et al.
Publicado: (2022)

Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the USA
por: Cheng, Mindy M., et al.
Publicado: (2023)

Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data
por: De Vito, Andrea, et al.
Publicado: (2023)

Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022
por: Suarez Castillo, Milena, et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras
por: Saá, Paula, et al.
Publicado: (2023)

Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants
por: Tartof, Sara Y, et al.
Publicado: (2022)

Highly Thermotolerant SARS-CoV-2 Vaccine Elicits Neutralising Antibodies against Delta and Omicron in Mice
por: Jansen van Vuren, Petrus, et al.
Publicado: (2022)

Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study
por: Stowe, Julia, et al.
Publicado: (2022)

Case-case study on comparative vaccine effectiveness against Delta and Omicron SARS-CoV-2 infections
por: Kislaya, I, et al.
Publicado: (2022)

Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England
por: Kirsebom, Freja Cordelia Møller, et al.
Publicado: (2022)

Neutralization Effect of Sera against Delta and Omicron in Patients Recovering from COVID-19 and Inactivated Vaccine Recipients
por: Zhu, Yajuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eisk2h9ldn9sq432qpqqthranj